Effects of Intermedin(1-53) on Cardiac Function and Ischemia/reperfusion Injury in Isolated Rat Hearts
Overview
Authors
Affiliations
Intermedin (IMD) is a novel member of the calcitonin/calcitonin gene-related peptide (CT/CGRP) family identified from human and other vertebrate tissues. Preprointermedin (preproIMD) can generate a 47 amino acid mature peptide (IMD(1-47)) and a shorter 40 amino acid one (IMD(8-47)) by proteolytic cleavage. Amino acid sequence analysis showed that cleavage sites are located between two basic amino acids at Arg93-Arg94, resulting in the production of preproIMD(95-147), namely IMD(1-53). The present study was designed to observe the effects of IMD(1-53) on cardiac function in ischemia/reperfusion (I/R) injury in isolated rat hearts. Perfusion with high-dose IMD(1-53) gave higher left ventricular systolic pressure (LVSP) and maximal rate of increase and decrease of left ventricle pressure (+/-LVdP/dt(max)), and coronary perfusion flow (CPF) than those of controls. Cardiac I/R induced a marked inhibition of cardiac function and myocardial injury. Reperfusion with IMD(1-53) significantly ameliorated the inhibited cardiac function and bradycardia induced by I/R. Compared with the I/R-treatment alone, IMD(1-53) reperfusion augmented CPF, LVSP, and maximal rate of increase and decrease of left ventricle pressure (+/-LVdP/dt(max)) and decreased LVDP. In addition, reperfusion with IMD(1-53)markedly attenuated the leakage of lactate dehydrogenase and malondialdehyde content in myocardia compared with I/R alone. Reperfusion with IMD(1-53)increased the content of cyclic adenosine monophosphate in comparison with I/R alone. Interestingly, the above IMD(1-53) effects are similar to those of adrenomedullin. These results suggest that IMD(1-53), like adrenomedullin, has cardioprotective effects against myocardial I/R injury.
Adipose ADM2 ameliorates NAFLD promotion of ceramide catabolism.
Wang P, Zhang S, Dong Y, Zeng G, Liu H, Wang X Acta Pharm Sin B. 2024; 14(11):4883-4898.
PMID: 39664433 PMC: 11628856. DOI: 10.1016/j.apsb.2024.09.010.
Intermedin Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis.
Zhang L, Zhang J, Hou Y, Lu W, Ni X, Lin F Inflammation. 2022; 45(4):1568-1584.
PMID: 35175495 DOI: 10.1007/s10753-022-01642-z.
Zhang P, Liu B Dis Markers. 2021; 2021:8116633.
PMID: 34853624 PMC: 8629660. DOI: 10.1155/2021/8116633.
Ni X, Zhang Y, Jia L, Lu W, Zhu Q, Ren J Aging (Albany NY). 2021; 13(4):5164-5184.
PMID: 33535178 PMC: 7950288. DOI: 10.18632/aging.202436.
Vazquez R, Riveiro M, Berenguer-Daize C, OKane A, Gormley J, Touzelet O Front Oncol. 2021; 10:589218.
PMID: 33489885 PMC: 7815935. DOI: 10.3389/fonc.2020.589218.